一个关于两个抑制剂的故事:二基诺林和四胺
James Chen1,2, Damian C Ekiert1,2
1Department of Cell Biology, NYU School of Medicine, New York, NY, USA.
The EMBO journal
|July 12, 2023
概括
新的结核病药物,贝达基林和TBAJ-876,阻断了必不可少的酶运动. 这些化合物通过防止其功能所需的旋转运动来抑制细胞呼吸至关重要的真菌细菌腺三酸盐 (ATP) 合成酶.
科学领域:
- 生物化学 生物化学
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
背景情况:
- 多药耐药结核病 (MDR-TB) 构成了全球重大卫生挑战.
- 贝达基林 (Bedaquiline,简称BDQ) 是一种FDA批准的药物,用于治疗多耐药结核病,其向的是菌根细菌的腺三酸盐 (ATP) 合成酶.
- 了解与ATP合成酶的药物相互作用对于开发新的抗结核病药物至关重要.
研究的目的:
- 调查Mycobacterium smegmatis ATP合成酶与新型二甲基诺林TBAJ-876和胺抑制剂SQ31f.f.的相互作用.
- 阐明这些抑制剂影响ATP合成酶功能的机制.
主要方法:
- 酶动力学测试. 酶动力学测试.
- 生物物理技术研究蛋白质运动.
- 在体外分析抑制剂与ATP合成酶结合.
主要成果:
- 显示TBAJ-876和SQ31f都与Mycobacterium smegmatis ATP合成酶发生相互作用.
- 抑制剂有效地阻止了对于酶的催化活性至关重要的旋转运动.
- 酶运动的这种破坏是这些化合物的抑制作用的基础.
结论:
- 第二代二基诺林和二胺抑制剂是向菌根性ATP合成酶的有希望的策略.
- 抑制ATP合成酶的旋转功能是开发新的抗结核药物的可行机制.
- 对这些抑制剂的进一步研究可能会导致对耐药结核病的治疗方法得到改善.
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
41
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
41
Antihypertensive Drugs: Thiazide-Class Diuretics
754
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
754
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.0K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K


